__timestamp | ADMA Biologics, Inc. | Telix Pharmaceuticals Limited |
---|---|---|
Wednesday, January 1, 2014 | 5915545 | 28336824 |
Thursday, January 1, 2015 | 7177633 | 32319194 |
Friday, January 1, 2016 | 10661037 | 29404631 |
Sunday, January 1, 2017 | 22760560 | 31769230 |
Monday, January 1, 2018 | 16985290 | 20439380 |
Tuesday, January 1, 2019 | 29349083 | 24186536 |
Wednesday, January 1, 2020 | 42219783 | 4680000 |
Friday, January 1, 2021 | 80942625 | 4898000 |
Saturday, January 1, 2022 | 154079692 | 155984000 |
Sunday, January 1, 2023 | 258214999 | 496659000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, Telix Pharmaceuticals Limited and ADMA Biologics, Inc. have showcased remarkable revenue trajectories over the past decade. From 2014 to 2023, Telix Pharmaceuticals experienced a staggering growth, culminating in a 1,650% increase in revenue by 2023. Meanwhile, ADMA Biologics also demonstrated impressive growth, with a 4,260% rise in revenue during the same period.
This comparison underscores the potential and resilience of biotech companies in navigating market challenges and capitalizing on growth opportunities.
Johnson & Johnson or Telix Pharmaceuticals Limited: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: GSK plc vs ADMA Biologics, Inc.
BeiGene, Ltd. vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Jazz Pharmaceuticals plc vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
Halozyme Therapeutics, Inc. and ADMA Biologics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Telix Pharmaceuticals Limited and Merus N.V. Performance Compared
Telix Pharmaceuticals Limited and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Telix Pharmaceuticals Limited vs Supernus Pharmaceuticals, Inc.
Annual Revenue Comparison: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Perrigo Company plc
Comparing Revenue Performance: ADMA Biologics, Inc. or Geron Corporation?
ADMA Biologics, Inc. and Galapagos NV: A Comprehensive Revenue Analysis